Moreover, the TCGA data also suggested that high expression of USP35 was associated with increased cancer mutational in CRC patients and higher recurrence rate in CRC patients receiving postoperative chemotherapy (Fig. 1E, F). This evidence concerns the gene USP35 and cancer.